Search clinical trials for: SARS-CoV-2/COVID-19

Total 59236 results

Rohto Pharmaceutical Co., Ltd.

Completed

A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)

SARS-CoV-2 Infection( COVID-19 )

Japan
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Recruiting

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
Butantan Institute

Active, not recruiting

Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine (Butanvac)

Coronavirus Infections | Healthy

Brazil
Direct Biologics, LLC

Available

Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS

Hypoxia | Covid19 | ARDS | Cytokine Storm
Institut National de la Santé Et de la Recherche...

Completed

Trial of Treatments for COVID-19 in Hospitalized Adults (DisCoVeRy)

Corona Virus Infection

Norway, Austria, France, Greece, Portugal, Belgium, Luxembourg
Lisa Barrett
Nova Scotia Health Authority; Dalhousie University

Active, not recruiting

Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients

COVID-19

Canada
Butantan Institute

Completed

Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil (ADAPTCOV)

Coronavirus Infections | Healthy

Brazil
Bryan Burt, MD
Brigham and Women's Hospital

Completed

Cyclosporine For The Treatment Of COVID-19(+)

SARS (Disease)

United States
Jonathan Gerber

No longer available

Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19

COVID | Corona Virus Infection | Sars-CoV2

United States
Geropharm

Completed

Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) in Healthy Volunteers and Outpatients With COVID-19

Pharmacokinetics | Efficacy | Safety Issues

Russian Federation
xCures
Cancer Commons; Genetic Alliance; LunaDNA; REDCap Cloud

Completed

Behavior, Environment And Treatments for Covid-19 (BEAT19)

Coronavirus

United States
University of Minnesota
Bill and Melinda Gates Foundation

Completed

Losartan for Patients With COVID-19 Requiring Hospitalization

Acute Respiratory Distress Syndrome | Corona Virus Infection | SARS-CoV Infection

United States
Adaptive Biotechnologies
Covance

Completed

ImmuneSense™ COVID-19 Study

SARS-CoV-2 Infection | Coronavirus Disease (COVID-19)

United States
Brigham and Women's Hospital

Withdrawn

Lung Irradiation for COVID-19 Pneumonia

SARS-CoV 2

United States
University Hospital, Strasbourg, France

Completed

Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic

Covid-19

France
Assistance Publique - Hôpitaux de Paris
Fonds IMMUNOV

Completed

Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) (AMBUCOV)

Covid19 | SARS-CoV-2

France
Corvus Pharmaceuticals, Inc.

Completed

Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients

COVID-19

United States
Oxford University Clinical Research Unit, Vietnam
National Hospital for Tropical Diseases, Hanoi, Vietnam; Ministry of Health... and other collaborators

Completed

The Vietnam Chloroquine Treatment on COVID-19 (VICO)

COVID-19 | SARS-CoV-2 Infection

Vietnam
University of Colorado, Denver

No longer available

Convalescent Plasma for the Treatment of Patients With COVID-19

COVID-19 | SARS-CoV 2

United States
Hospital de Mataró

Unknown

Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19) (SERO-MARES)

SARS-CoV 2 | Covid19 | COVID | Corona Virus Infection

Spain
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Recruiting

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
Genova Inc.

Recruiting

Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19 (NOVATION-1)

Covid19

Turkey, Malaysia, Brazil, Argentina, Canada, Chile, Colombia, Indonesia, Kenya, Peru, South Africa, Ukraine
Ina-Respond
Center for Research and Development of Health Resources and Services, National...

Recruiting

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia (FVR)

Covid19 | Infectious Disease | SARS-CoV Infection

Indonesia
AstraZeneca

Completed

An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan (Evusheld DBR)

COVID-19

Japan
European University at St. Petersburg

Completed

Study of the Spread of COVID-19 in Saint Petersburg, Russia

COVID19

Russian Federation
University of California, San Francisco

Terminated

DISulfiram for COvid-19 (DISCO) Trial (DISCO)

Covid19

United States
Fundacion SEIMC-GESIDA

Completed

Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain (COVID19@Spain)

Covid19

Spain
Sinocelltech Ltd.

Active, not recruiting

A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
Pardes Biosciences, Inc.

Active, not recruiting

PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19

COVID-19

United States
AnGes, Inc.
Japan Agency for Medical Research and Development

Completed

Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose)

COVID-19 Lower Respiratory Infection

Japan
Corvus Pharmaceuticals, Inc.

Terminated

CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients

Covid-19

United States, Colombia, Spain, Canada, Peru, Brazil, Italy, Argentina, Chile, Germany, Mexico, Ukraine
AnGes, Inc.
Japan Agency for Medical Research and Development

Completed

Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)

COVID-19

Japan
Hackensack Meridian Health

Active, not recruiting

A Prospective "Universal" Observational Database for COVID-19

COVID-19

United States
IRCCS San Raffaele

Active, not recruiting

Establishment of a Biological Biobank of Subjects Vaccinated Against SARS-CoV-2 Infection (COVID-19)

Coronavirus Infections

Italy
National Research Center - Institute of Immunology...
St. Petersburg Research Institute of Vaccines and Sera

Completed

The siCoV/KK46 Drug Open-safety Study

COVID-19

Russian Federation
Centre de recherche du Centre hospitalier universitaire...
Lallemand Health Solutions

Completed

Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19 (PROVID-19)

COVID-19

Canada
University Hospital Southampton NHS Foundation...
University of Southampton

Active, not recruiting

Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study (INFLAME)

Covid19 | SARS-CoV-2 Infection

United Kingdom
University of Minnesota
University of Manitoba; University of Alberta; McGill University Health Centre...

Completed

Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP)

Coronavirus Infections | Acute Respiratory Distress Syndrome | Corona Virus Infection | SARS-CoV Infection | Coronavirus

United States, Canada
Hospital del Río Hortega

Completed

Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study) (DECORE)

SARS-CoV 2 | COVID

Spain
St George's, University of London

Unknown

Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak)

COVID-19

United Kingdom
Meshalkin Research Institute of Pathology of Circulation

Unknown

SARS-CoV-2 Disguise Study (Disguise)

Sars-CoV2

Russian Federation
Assistance Publique - Hôpitaux de Paris

Recruiting

Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 (DEXDO-COVID)

SARS-CoV 2

France
University of Cologne
Boehringer Ingelheim; ZKS Köln

Completed

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion

SARS-CoV-2 Infection

Germany
Direction Centrale du Service de Santé des Armées
University Hospital, Grenoble

Terminated

Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients. (PLASCOSSA)

COVID-19

France
University of Cologne
Boehringer Ingelheim; ZKS Köln

Completed

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation

SARS-CoV-2 Infection

Germany
NEURALIS s.a.

Active, not recruiting

Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection

Covid19

Belgium, Hungary, Russian Federation, Poland
University of Bonn

Recruiting

Precision Immunology to Determine the Immune Response in Patients With COVID-19

SARS-CoV 2 | COVID

Germany

Search clinical trials for: SARS-CoV-2/COVID-19

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations